
Sign up to save your podcasts
Or


A 2019 report from the National Academies of Sciences, Engineering, and Medicine lays out irrefutable evidence that medications like methadone can save lives when used for opioid use disorder, but decades of policy rooted in racism and stigma keeps methadone largely out of reach for those who need it. Alan Leshner, CEO emeritus of the American Association for the Advancement of Science and chair of the planning committee for the report talks with Lindsay Smith Rogers about these policies and why this is a moment of opportunity to enact major reform in the methadone system and address the opioid epidemic. Read the full report here.
By The Johns Hopkins Bloomberg School of Public Health4.6
618618 ratings
A 2019 report from the National Academies of Sciences, Engineering, and Medicine lays out irrefutable evidence that medications like methadone can save lives when used for opioid use disorder, but decades of policy rooted in racism and stigma keeps methadone largely out of reach for those who need it. Alan Leshner, CEO emeritus of the American Association for the Advancement of Science and chair of the planning committee for the report talks with Lindsay Smith Rogers about these policies and why this is a moment of opportunity to enact major reform in the methadone system and address the opioid epidemic. Read the full report here.

43,587 Listeners

40 Listeners

5 Listeners

27 Listeners

5 Listeners

262 Listeners

56,524 Listeners

495 Listeners

9 Listeners

45 Listeners

93 Listeners

16,355 Listeners

16 Listeners

4,752 Listeners

2 Listeners

4,486 Listeners

391 Listeners

6,552 Listeners

25 Listeners

6,389 Listeners

236 Listeners

65 Listeners

164 Listeners

98 Listeners